Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LXX.CN)

Lexaria Bioscience Corp (LXX.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 48,016
  • Shares Outstanding, K 89,587
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 1.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.91
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings -0.02 on 05/31/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.320 +68.75%
on 07/09/20
0.690 -21.74%
on 07/20/20
+0.150 (+38.46%)
since 07/03/20
3-Month
0.310 +74.19%
on 05/14/20
0.690 -21.74%
on 07/20/20
+0.140 (+35.00%)
since 05/05/20
52-Week
0.310 +74.19%
on 05/14/20
1.270 -57.48%
on 08/12/19
-0.360 (-40.00%)
since 08/02/19

Most Recent Stories

More News
Medical Marijuana Market 2020 Industry Size, Growth, Trends, Segments and Cost Structure Analysis Research Report 2028

Research Nester published a report titled  which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.

ACB.TO : 14.18 (-0.35%)
LXX.CN : 0.540 (+3.85%)
TLRY : 8.11 (-6.78%)
WEED.TO : 25.49 (-0.82%)
APHA : 4.81 (-1.64%)
GWPH : 134.94 (-0.32%)
ACB : 10.71 (-0.19%)
MRRCF : 0.0036 (-16.28%)
LXRP : 0.4000 (unch)
CNABQ : 0.0138 (+2.22%)
Lexaria BioScience Receives Ethics Board Approval to Conduct Exploratory Clinical Study using Cannabidiol for Blood Pressure Reduction

Complements previously published data that cites Lexaria's TurboCBD to demonstrate a significant 5% reduction in mean arterial blood pressure

LXRP : 0.4000 (unch)
LXX.CN : 0.540 (+3.85%)
Marijuana Market : Industry Analysis and Forecast 2020-2025) -By Product Type, Formulation, and Region

Global Marijuana Market was valued at USD 17.2 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.9% from 2019 to reach USD 88.97 Billion by the year 2025. North...

ACB.TO : 14.18 (-0.35%)
CBDS : 0.5510 (+2.04%)
CGRW : 0.0860 (-1.15%)
GRNH : 0.0030 (+11.11%)
LXX.CN : 0.540 (+3.85%)
MJNA : 0.0143 (-0.69%)
CNAB : 0.0165 (-65.63%)
Lexaria BioScience Files Application with Senior U.S. Stock Exchange for Uplisting

KELOWNA, BC / ACCESSWIRE / July 21, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has filed an application...

LXRP : 0.4000 (unch)
LXX.CN : 0.540 (+3.85%)
Covid-19 impact on Legalized Cannabis Market Research Report 2020-2029 | Aurora Cannabis Inc., Aphria Inc., Canopy Growth Corporation, MedReleaf Corp, The Cronos Group

XXII : 0.7452 (-2.14%)
APHA : 4.81 (-1.64%)
ACB.TO : 14.18 (-0.35%)
HEMP : 0.0050 (unch)
LXX.CN : 0.540 (+3.85%)
MEDFF : 18.8100 (-0.37%)
Altria and Lexaria Conclude Phase I Research and Development Program

R&D Program Utilized Lexaria's Patented DehydraTECHTM Technology for Oral Nicotine Delivery

LXX.CN : 0.540 (+3.85%)
LXRP : 0.4000 (unch)
Medical Marijuana Market 2020 Global Opportunities, Driving Forces, COVID-19 Impact Analysis, Future Potential 2028

(MENAFN - Comserve) New York, United States, Jul 14, 2020, 04:41 /Comserve / -- The market is anticipated to witness a significant CAGR during the forecast period, i.e. 2020-2028. The growth can be witnessed...

ACB.TO : 14.18 (-0.35%)
LXX.CN : 0.540 (+3.85%)
TLRY : 8.11 (-6.78%)
WEED.TO : 25.49 (-0.82%)
APHA : 4.81 (-1.64%)
GWPH : 134.94 (-0.32%)
ACB : 10.71 (-0.19%)
MRRCF : 0.0036 (-16.28%)
LXRP : 0.4000 (unch)
CNABQ : 0.0138 (+2.22%)
Medical Marijuana Market 2020 Global Opportunities, Driving Forces, COVID-19 Impact Analysis, Future Potential 2028

New York, United States, Tue, 14 Jul 2020 04:41:33 / Comserve Inc. / -- The market is anticipated to witness a significant CAGR during the forecast period, i.e. 2020-2028. The growth can be witnessed concerning...

ACB.TO : 14.18 (-0.35%)
LXX.CN : 0.540 (+3.85%)
TLRY : 8.11 (-6.78%)
WEED.TO : 25.49 (-0.82%)
APHA : 4.81 (-1.64%)
GWPH : 134.94 (-0.32%)
ACB : 10.71 (-0.19%)
MRRCF : 0.0036 (-16.28%)
LXRP : 0.4000 (unch)
CNABQ : 0.0138 (+2.22%)
Lexaria Announces 2020 Annual and Special Meeting Results

(via TheNewswire)

LXRP : 0.4000 (unch)
LXX.CN : 0.540 (+3.85%)
Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License

(via TheNewswire)

LXRP : 0.4000 (unch)
LXX.CN : 0.540 (+3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

2nd Resistance Point 0.553
1st Resistance Point 0.547
Last Price 0.540
1st Support Level 0.527
2nd Support Level 0.513

See More

52-Week High 1.270
Fibonacci 61.8% 0.903
Fibonacci 50% 0.790
Fibonacci 38.2% 0.677
Last Price 0.540
52-Week Low 0.310

See More

Business Summary

Lexaria Bioscience Corp is a food science company. The company's food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy....

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar